ZALICUS
Zalicus Inc., formerly CombinatoRx, Incorporated, is a biopharmaceutical company engaged in developing drug candidates with a focus on the treatment of pain and inflammation. The Company has devoted substantially all of its resources to the development of its drug discovery technology and the research and development of its drug candidates, including conducting preclinical and clinical trials and seeking intellectual property protection for its technology and product candidates. On March 1, 2010... , the United States Food and Drug Administration, (FDA), approved the New Drug Application (NDA) for Exalgo (hydromorphone HCl) extended-release tablets, for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time. On December 21, 2009, the Company merged with Neuromed Pharmaceuticals, Inc. and its subsidiaries.
ZALICUS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2000-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.zalicus.com
Total Employee:
11+
Status:
Active
Contact:
6173017010
Total Funding:
84.98 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Content Delivery Network Amazon OpenResty AdBlock Acceptable Ads Citrix NetScaler Bodis DNS
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2009-12-21 | Neuromed Pharmaceuticals | Neuromed Pharmaceuticals acquired by Zalicus | N/A |
Investors List
TL Ventures
TL Ventures investment in Series E - Zalicus
Flagship Pioneering
Flagship Pioneering investment in Series D - Zalicus
Easton Capital
Easton Capital investment in Series D - Zalicus
Global Life Science Ventures
Global Life Science Ventures investment in Series D - Zalicus
Canaan Partners
Canaan Partners investment in Series D - Zalicus
Yasuda Enterprise Development
Yasuda Enterprise Development investment in Series D - Zalicus
TL Ventures
TL Ventures investment in Series D - Zalicus
Boston Millennia Partners
Boston Millennia Partners investment in Series D - Zalicus
Canaan Partners
Canaan Partners investment in Series C - Zalicus
TL Ventures
TL Ventures investment in Series C - Zalicus
Official Site Inspections
http://www.zalicus.com
- Host name: ec2-13-56-33-8.us-west-1.compute.amazonaws.com
- IP address: 13.56.33.8
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
